Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Exploring the genetics of lithium response in bipolar disorders

    Lithium (Li) remains the treatment of choice for bipolar disorders (BP). Its mood-stabilizing effects help reduce the long-term burden of mania, depression and suicide risk in patients with BP. It also has bee...

    Marisol Herrera-Rivero, Mazda Adli in International Journal of Bipolar Disorders (2024)

  2. No Access

    Article

    Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets

    Patients with severe mental disorders such as bipolar disorder (BD), schizophrenia (SCZ) and major depressive disorder (MDD) show a substantial reduction in life expectancy, increased incidence of comorbid med...

    Claudia Pisanu, Donatella Congiu, Anna Meloni in Neuropsychopharmacology (2024)

  3. Article

    Open Access

    Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study

    Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study...

    Anna H. Ou, Sara B. Rosenthal, Mazda Adli, Kazufumi Akiyama in Translational Psychiatry (2024)

  4. Article

    Open Access

    Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder

    Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling mental health disorder that affects about 1% of the population worldwide. Nevertheless, lithium is not consiste...

    Azmeraw T. Amare, Anbupalam Thalamuthu, Klaus Oliver Schubert in Molecular Psychiatry (2023)

  5. Article

    Open Access

    Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder

    Sunlight contains ultraviolet B (UVB) radiation that triggers the production of vitamin D by skin. Vitamin D has widespread effects on brain function in both develo** and adult brains. However, many people l...

    Michael Bauer, Tasha Glenn, Eric D. Achtyes in International Journal of Bipolar Disorders (2023)

  6. No Access

    Article

    Renal function at follow-up in a cohort of patients who had shown reduced glomerular filtration rate during long-term treatment with lithium

    Alberto Bocchetta, Luca Ambrosiani, Francesca Sanna in Journal of Nephrology (2023)

  7. Article

    Open Access

    Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment

    It has been suggested that bipolar disorder (BD) is associated with clinical and biological features of accelerated aging. In our previous studies, we showed that long-term lithium treatment was correlated wit...

    Alessio Squassina, Anna Meloni, Donatella Congiu, Panagiotis Bosganas in Human Genomics (2022)

  8. Article

    Open Access

    Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients

    Klaus Oliver Schubert, Anbupalam Thalamuthu, Azmeraw T. Amare in Translational Psychiatry (2022)

  9. Article

    Open Access

    Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients

    Lithium is the gold standard therapy for Bipolar Disorder (BD) but its effectiveness differs widely between individuals. The molecular mechanisms underlying treatment response heterogeneity are not well unders...

    Klaus Oliver Schubert, Anbupalam Thalamuthu, Azmeraw T. Amare in Translational Psychiatry (2021)

  10. Article

    Open Access

    HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders

    Bipolar affective disorder (BD) is a severe psychiatric illness, for which lithium (Li) is the gold standard for acute and maintenance therapies. The therapeutic response to Li in BD is heterogeneous and relia...

    Sigrid Le Clerc, Laura Lombardi, Bernhard T. Baune, Azmeraw T. Amare in Scientific Reports (2021)

  11. Article

    Open Access

    Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder

    Bipolar disorder is associated with circadian disruption and a high risk of suicidal behavior. In a previous exploratory study of patients with bipolar I disorder, we found that a history of suicide attempts w...

    Michael Bauer, Tasha Glenn, Eric D. Achtyes in International Journal of Bipolar Disorders (2021)

  12. No Access

    Article

    Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions

    Patients with bipolar disorder (BD) often show increased risk-taking propensity, which may contribute to poor clinical outcome. While these two phenotypes are genetically correlated, there is scarce knowledge ...

    Claudia Pisanu, Donatella Congiu, Giovanni Severino in Neuropsychopharmacology (2021)

  13. No Access

    Article

    Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

    Lithium is a first-line medication for bipolar disorder (BD), but only one in three patients respond optimally to the drug. Since evidence shows a strong clinical and genetic overlap between depression and bip...

    Azmeraw T. Amare, Klaus Oliver Schubert, Li** Hou, Scott R. Clark in Molecular Psychiatry (2021)

  14. Article

    Open Access

    Prediction of lithium response using genomic data

    Predicting lithium response prior to treatment could both expedite therapy and avoid exposure to side effects. Since lithium responsiveness may be heritable, its predictability based on genomic data is of inte...

    William Stone, Abraham Nunes, Kazufumi Akiyama, Nirmala Akula in Scientific Reports (2021)

  15. Article

    Open Access

    Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder

    Predicting lithium response (LiR) in bipolar disorder (BD) may inform treatment planning, but phenotypic heterogeneity complicates discovery of genomic markers. We hypothesized that patients with “exemplary ph...

    Abraham Nunes, William Stone, Raffaella Ardau, Anne Berghöfer in Translational Psychiatry (2021)

  16. No Access

    Article

    Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications

    Individuals with severe psychiatric disorders have a reduced life expectancy compared to the general population. At the biological level, patients with these disorders present features that suggest the involve...

    Alessio Squassina, Mirko Manchia, Claudia Pisanu in Neuropsychopharmacology (2020)

  17. Article

    Open Access

    Internet use by older adults with bipolar disorder: international survey results

    The world population is aging and the number of older adults with bipolar disorder is increasing. Digital technologies are viewed as a framework to improve care of older adults with bipolar disorder. This anal...

    Rita Bauer, Tasha Glenn, Sergio Strejilevich in International Journal of Bipolar Disorders (2018)

  18. Article

    Open Access

    Circulating antithyroid antibodies contribute to the decrease of glomerular filtration rate in lithium-treated patients: a longitudinal study

    Concerns about the adverse effects of long-term treatment with lithium include reduced renal function. In the present study, we examined comorbidities which may be associated with chronic kidney disease in a c...

    Alberto Bocchetta, Luca Ambrosiani in International Journal of Bipolar Disorders (2018)

  19. No Access

    Article

    Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients

    Lithium has been used for more than six decades for the management of bipolar disorder (BD). In a previous transcriptomic study, we showed that patients affected by either BD or cluster headache, both disorder...

    Eleni Merkouri Papadima, Paola Niola, Carla Melis in Journal of Molecular Neuroscience (2017)

  20. Article

    Open Access

    An observational study of 110 elderly lithium-treated patients followed up for 6 years with particular reference to renal function

    Recent observational studies have focused on lithium treatment in the elderly, with particular reference to safety in terms of thyroid and renal functions. The purpose of this study was to compare the clinical...

    Alberto Bocchetta, Francesca Cabras in International Journal of Bipolar Disorders (2017)

previous disabled Page of 2